Published in:
Open Access
01-12-2006 | Case report
Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole
Authors:
Dae Won Park, Jang Wook Sohn, Hee Jin Cheong, Woo Joo Kim, Min Ja Kim, Je Hyeong Kim, Chol Shin
Published in:
BMC Infectious Diseases
|
Issue 1/2006
Login to get access
Abstract
Background
The current recommended therapy for diffuse coccidioidal pneumonia involves initial treatment with amphotericin B deoxycholate or high-dose fluconazole, followed by an azole after clinical improvement. Amphotericin B is more frequently used as initial therapy if the patient's deterioration is rapid.
Case presentation
A 31-year-old Korean male with coccidioidomycosis presented to the hospital with miliary infiltrates on chest X-ray (CXR) and skin rash on the face and trunk. Initially, the patient did not respond to amphotericin B deoxycholate therapy. However, following caspofungin and fluconazole combination therapy, the patient showed favourable radiological, serological, and clinical response.
Conclusion
This appears to be the first case of diffuse coccidioidal pneumonia with skin involvement in an immunocompetent patient who was treated successfully with caspofungin and fluconazole. Combination therapy with caspofungin and fluconazole may, therefore, be an alternative treatment for diffuse coccidioidal pneumonia that does not respond to amphotericin B deoxycholate therapy.